Search
Inhibikase Therapeutics Inc
IKTAdd to Watchlist
2.100USD
-0.050-2.33%
Close 09-24 16:00（ET）
329.76MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.33%
5 Days
-8.70%
1 Month
-16.00%
6 Months
+31.25%
Year to Date
+2.44%
1 Year
+22.09%
Key Figures
2.150Open
2.310High
54.48KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
2.150Prev. Close
2.080Low
115.13KTurnover
LossP/E Static
2.17P/B
0.00%Div Yield TTM
-38.09%ROA
2.61052wk High
21.54Volume Ratio
-27.52MNet Profit
157.03MShares
-0.4332EPS TTM
0.94Beta
-40.23%ROE
1.33052wk Low
10.70%Amplitude
100.00%Gross Margin
329.76MMarket Cap
2.10Reward/Risk
3.94%Risk Rate
More news coming soon, stay tuned...
Inhibikase Therapeutics Inc's Score
0.06vs previous score
Forecast8.89
Financial Health6.59
Technical4.08
Valuation Dimensions7.03
Institutional Confidence7.00
Risk Assessment4.60
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Inhibikase Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.11/-0.11
Revenue / Forecast
--/0.00
Inhibikase Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolIKT
Number of employees15
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Sands Capital Ventures LLC | 9.86% |
| Soleus Capital Management, L.P. | 8.24% |
| Fairmount Funds Management LLC | 6.53% |
| Adar1 Capital Management LLC | 6.11% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 43.67% |
| Investment Advisor | 20.91% |
| Investment Advisor/Hedge Fund | 9.78% |
| Corporation | 4.42% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%Popular Instruments
51402.200
+105.200 (+0.20%)
30569.000
+126.500 (+0.42%)
7708.100
+13.300 (+0.17%)
14201.000
-59.000 (-0.41%)
66351.000
+702.000 (+1.07%)
6320.800
+20.600 (+0.33%)
92.027
-2.406 (-2.55%)
335.920
-1.100 (-0.33%)
224.580
-0.930 (-0.41%)
4271.030
-3.730 (-0.09%)
FAQs
What is the current price of Inhibikase Therapeutics Inc (IKT)?
The current price of Inhibikase Therapeutics Inc (IKT) is 2.10.
What is the symbol of Inhibikase Therapeutics Inc?
The ticker symbol of Inhibikase Therapeutics Inc is IKT.
What is the 52-week high of Inhibikase Therapeutics Inc?
The 52-week high of Inhibikase Therapeutics Inc is 2.61.
What is the 52-week low of Inhibikase Therapeutics Inc?
The 52-week low of Inhibikase Therapeutics Inc is 1.33.
What is the market capitalization of Inhibikase Therapeutics Inc?
The market capitalization of Inhibikase Therapeutics Inc is 329.76M.
Is Inhibikase Therapeutics Inc (IKT) currently rated as Buy, Hold, or Sell?
According to analysts, Inhibikase Therapeutics Inc (IKT) has an overall rating of Buy, with a price target of 6.00.
What is the Earnings Per Share (EPS TTM) of Inhibikase Therapeutics Inc (IKT)?
The Earnings Per Share (EPS TTM) of Inhibikase Therapeutics Inc (IKT) is -0.43.